Irene Ghobrial, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Irene Ghobrial, Dana-Farber Cancer Institute

Caption

Dr. Irene Ghobrial led a study showing a drug that targets the driver mutation in patients with Waldenstrom's Macrogloblinemia is proving effective in animal studies.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.